Login / Signup

How to break resistance to hedgehog inhibitors in advanced basal cell carcinoma?

Egle RamelyteG RestivoL ImhofMirjam NägeliReinhard Dummer
Published in: The British journal of dermatology (2020)
Egle Ramelyte has intermittent, project focused consulting or research relationships with Amgen, Novartis, Sanofi, Pierre Fabre and Galderma outside the submitted work. Mirjam Nägeli has intermittent, project focused consulting and/or advisory relationships with Sanofi, SunPharma outside the submitted work. Laurence Imhof has intermittent, project focused consulting and/or advisory relationships with Galderma outside the submitted work.
Keyphrases
  • quality improvement
  • basal cell carcinoma
  • high intensity